Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.46 |
| ▸ | CA1 | P00915 | 11/20 | 0.46 |
| ▸ | CA12 | O43570 | 5/20 | 0.45 |
| ▸ | CA9 | Q16790 | 5/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 2/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6552837 | 0.85 | CA2 (0.48) | CA2CA1CA12CA9HTR2A | |
| SCHEMBL6554319 | 0.81 | HTR2A (0.49) | CA2CA1CA12CA9HTR2A | |
| SCHEMBL6539934 | 0.77 | CA2 (0.48) | CA2CA1CA12CA9 | |
| SCHEMBL4275420 | 0.76 | CA1 (0.48) | CA2CA1CA12CA9NAMPT | |
| SCHEMBL6540455 | 0.74 | ALDH1A1 (0.50) | CA2CA1CA12CA9HTR2A | |
| SCHEMBL6554338 | 0.73 | ADRB3 (0.53) | — | |
| SCHEMBL31748114 | 0.72 | CA2 (0.63) | CA2CA1CA12CA9NAMPT | |
| SCHEMBL3634189 | 0.72 | MEN1 (0.52) | CA2CA1NAMPT | |
| SCHEMBL3634801 | 0.72 | MAPT (0.48) | CA2CA1NAMPT | |
| SCHEMBL4434314 | 0.71 | CA1 (0.47) | CA2CA1CA12CA9NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1389185-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002094770-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-28 | — | — | WO | disclosed |